Health ❯ Healthcare ❯ Medical Research ❯ Cancer Research

Pancreatic Cancer

KRAS Vaccine Elicits Durable Immune Response and Is Well Tolerated in High‑Risk Pancreatic Cohort

Investigators say the phase 1 immune results justify tissue-based follow-up studies and larger trials to test whether vaccination can prevent pancreatic cancer.

35 ARTICLES

2mo ago

Daraxonrasib Doubles Survival in Treated Metastatic Pancreatic Cancer in Phase 3 Trial

4 ARTICLES

2mo ago

NADPH Disruption Fuels Early Pancreatic Lesions as ME1 Loss Drives Cancer Progression

4 ARTICLES

6mo ago

Triple Therapy Eradicates Pancreatic Tumors in Mice in CNIO Study

3 ARTICLES

6mo ago

Four-Marker Blood Test Shows About 92% Accuracy for Early Pancreatic Cancer in Retrospective Study

3 ARTICLES

6mo ago

NIH-Supported Study Unveils Four-Marker Blood Test for Earlier Detection of Pancreatic Cancer

16 ARTICLES

6mo ago

Spanish Team Eradicates Pancreatic Tumors in Mice With Triple-Drug Regimen, PNAS Study Finds

19 ARTICLES

6mo ago

Triple-Drug Strategy Wipes Out Pancreatic Tumors in Mice, Study Finds

3 ARTICLES

7mo ago

Low CTDNEP1 Tied to Poorer Outcomes in Pancreatic Cancer, Study Finds

8 ARTICLES

9mo ago

UK Launches National Trial of Breath Test to Spot Pancreatic Cancer Early

3 ARTICLES

10mo ago

Scientists Pinpoint SPP1 as Drug Target to Halt Pancreatic Cancer Spread

13 ARTICLES

10mo ago

27 Oral Microbes Tied to 3.5-Fold Higher Pancreatic Cancer Risk in Large Saliva Study

3 ARTICLES

this yr.

KRAS-Targeted Vaccine Shows Robust Immune Response, Longer-Than-Expected Survival in Pancreatic and Colorectal Cancer Trial

17 ARTICLES

last yr.

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

Pancreatic Cancer

KRAS Vaccine Elicits Durable Immune Response and Is Well Tolerated in High‑Risk Pancreatic Cohort

Daraxonrasib Doubles Survival in Treated Metastatic Pancreatic Cancer in Phase 3 Trial

Low‑Risk Pancreatic Cysts Linked to Much Higher Long‑Term Cancer Risk

NEJM Study and FDA Access Advance Daraxonrasib for Pancreatic Cancer

Mayo Clinic AI Flags Pancreatic Cancer on CT Scans Up to Three Years Early

NADPH Disruption Fuels Early Pancreatic Lesions as ME1 Loss Drives Cancer Progression

Triple Therapy Eradicates Pancreatic Tumors in Mice in CNIO Study

Four-Marker Blood Test Shows About 92% Accuracy for Early Pancreatic Cancer in Retrospective Study

NIH-Supported Study Unveils Four-Marker Blood Test for Earlier Detection of Pancreatic Cancer

Spanish Team Eradicates Pancreatic Tumors in Mice With Triple-Drug Regimen, PNAS Study Finds

Never miss stories about

Pancreatic Cancer

Triple-Drug Strategy Wipes Out Pancreatic Tumors in Mice, Study Finds

Low CTDNEP1 Tied to Poorer Outcomes in Pancreatic Cancer, Study Finds

UK Launches National Trial of Breath Test to Spot Pancreatic Cancer Early

Scientists Pinpoint SPP1 as Drug Target to Halt Pancreatic Cancer Spread

27 Oral Microbes Tied to 3.5-Fold Higher Pancreatic Cancer Risk in Large Saliva Study

KRAS-Targeted Vaccine Shows Robust Immune Response, Longer-Than-Expected Survival in Pancreatic and Colorectal Cancer Trial

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

Never miss stories about

Pancreatic Cancer